A retrospective cohort study assessing the effects of Lusutrombopag on post-invasive procedural bleeding in Thrombocytopenic patients with Chronic Liver disease
Latest Information Update: 15 Nov 2021
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- Sponsors Shionogi
- 15 Nov 2021 New trial record
- 08 Nov 2021 Results published in the Advances in Therapy